Safety, tolerability, pharmacodynamics, and pharmacokinetics of rivaroxaban-an oral, direct factor Xa inhibitor-are not affected by aspirin - Kubitza,D.; Becka,M.; Mueck,W.; Zuehlsdorf,M. (J Clin Pharmacol, 2006)